Acute Upper Respiratory Infection: Treatment Guide
This paper provides a clinical overview of acute upper respiratory infections (URIs), commonly known as the common cold. It examines the causes and transmission of URIs, noting that rhinoviruses account for the majority of cases among more than 200 identified viral agents. The paper outlines both prescriptive drug therapies—including analgesics, antihistamines, decongestants, nasal steroids, expectorants, and anti-flu medications—and non-prescriptive approaches such as hydration, rest, saltwater gargles, and humidifier use. It also addresses the importance of avoiding antibiotic misuse for viral infections and concludes with patient-specific guidance for managing a child's URI symptoms during planned travel.
- Introduction to Acute Upper Respiratory Infection: Definition, prevalence, and overview of URI
- Causes and Transmission: How URI spreads and who is most at risk
- Prescriptive Drug Therapies: Medications used to manage URI symptoms
- Non-Prescriptive Drug Therapies: Home remedies and self-care strategies for URI
- Patient-Specific Guidance and Clinical Recommendations: Tailored advice for child patient and travel
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Clearly distinguishes between viral and bacterial causes of URI, providing a strong rationale for avoiding antibiotic misuse — a clinically important distinction supported by cited literature.
- Systematically organizes treatment options into prescriptive and non-prescriptive categories, making the content accessible and easy to follow for both clinical and general audiences.
- Grounds practical recommendations in patient-specific context (a child with URI facing travel), which bridges theoretical content with applied clinical decision-making.
Key academic technique demonstrated
The paper demonstrates effective use of evidence-based reasoning: each therapeutic recommendation is linked to a mechanism of action (e.g., why acetaminophen is preferred, why pseudoephedrine is contraindicated in certain populations), moving beyond listing drugs to explaining their clinical rationale. Citations from peer-reviewed sources (JAMA, Annals of Internal Medicine) lend authority to specific claims.
Structure breakdown
The paper opens with an epidemiological and pathophysiological introduction, followed by a section on transmission. It then proceeds through prescriptive therapies in descending specificity (analgesics to flu vaccines), followed by non-prescriptive home management strategies. The paper closes with individualized patient guidance, applying the prior content to a concrete clinical scenario — an effective problem-to-solution arc.
Introduction to Acute Upper Respiratory Infection
An acute upper respiratory infection (URI), also referred to as the common cold, normally affects the nasal passages and throat. The upper respiratory tract consists of the nose, pharynx, throat, bronchi, and larynx. Treatment for an acute URI is usually straightforward unless the patient has a chronic respiratory condition such as asthma. This is one of the most common illnesses, leading to more doctor visits and absenteeism from work and school than any other illness each year. During a one-year period, it is estimated that people in the United States will suffer one billion colds (Santee et al., 2016).
Acute URI is most often caused by a virus, although some cases may be caused by bacteria. The virus inflames the membranes lining the nose and throat. There are more than 200 different viruses that can cause colds, but rhinoviruses cause the majority of cases. While the common cold is the most well-known URI, others include sinusitis, epiglottitis, pharyngitis, and tracheobronchitis. It should be noted that influenza is not classified as a URI because it is a systemic illness.
An acute URI is normally harmless, although it may not feel that way. Children younger than six years are at the greatest risk of suffering from colds. Healthy adults can expect to have about two or three colds annually. A common cold will typically clear within a week or ten days. Smokers are likely to experience symptoms for longer periods. If symptoms do not improve as the days pass, one should see a doctor.
Causes and Transmission
The cold virus enters a person's body through the mouth, nose, or eyes. The virus can spread through droplets in the air after a sick person coughs, talks, or sneezes. It can also be spread by hand-to-hand contact with an infected person or by sharing contaminated objects such as utensils, toys, telephones, or towels. When a person touches their nose, mouth, or eyes after contact with an infected person, they are likely to catch a cold.
Children younger than six years are at a greater risk of getting colds, especially in child-care settings. These children do not yet have a fully developed immune system. Because children tend to touch their eyes, mouth, and nose frequently, they are particularly likely to contract or spread the virus.
Prescriptive Drug Therapies
No medication or prescription can cure an acute URI. The goal of medication is to ease symptoms and reduce the discomfort they cause. Silverman et al. (2017) caution that people should avoid taking antibiotics when they have an acute URI. Antibiotics cannot cure viruses; they are used only for treating bacterial infections. When people use antibiotics unnecessarily for URI, the body can develop antibiotic resistance, ultimately undermining the effectiveness of these drugs against infections they are designed to treat.
To ease the discomfort of an acute URI, the following medications may be considered. Analgesics are used for reducing pain and fever, with acetaminophen being the preferred option. However, patients should not take more than one drug containing acetaminophen, as excessive amounts can damage the liver. Aspirin should be avoided, as it may cause Reye's syndrome. Antihistamines can be used to dry out the nose, though patients should avoid driving or performing complex tasks while taking them, as these drugs cause drowsiness. Non-drowsy alternatives exist but may not be as effective at relieving symptoms.
Decongestants can relieve a clogged, stuffy nose. An oral decongestant such as pseudoephedrine may be tried; however, nervousness, insomnia, and irritability are possible side effects. Patients with uncontrolled high blood pressure or those who are pregnant should avoid pseudoephedrine products. Nasal steroids are used for the relief of a runny nose or sinus pressure, and antihistamines can assist as well. However, specific nasal steroids such as fluticasone or mometasone are more effective at relieving these symptoms (Aglipay et al., 2017). Fluticasone can be purchased without a prescription, while mometasone requires one.
Expectorants help to loosen mucus production and thin thick nasal discharge, making it easier to blow the nose and reducing congestion. This is particularly helpful for children who cannot blow their noses as forcefully as adults. Throat lozenges can be used to relieve a sore throat.
Prescription anti-flu medicines are another treatment option. They will not cure the flu but can make symptoms milder and help a patient recover more quickly. These drugs are effective only if used within the first 48 hours of developing flu-like symptoms. Such medicines include rimantadine, zanamivir, amantadine, and oseltamivir. They are generally reserved for people who are severely ill with the flu or who are at risk of complications, rather than for otherwise healthy individuals.
The flu vaccine can be administered either as a nasal spray or as a shot. There is no vaccine against the common cold, but a vaccine is available for preventing the flu. The vaccine works by exposing the immune system to the viruses, prompting the body to build antibodies against them.
References
Aglipay, M., Birken, C. S., Parkin, P. C., Loeb, M. B., Thorpe, K., Chen, Y., . . . Hoch, J. S. (2017). Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA, 318(3), 245–254.
Lee, R. J., & Cohen, N. A. (2015). Role of the bitter taste receptor T2R38 in upper respiratory infection and chronic rhinosinusitis. Current Opinion in Allergy and Clinical Immunology, 15(1), 14.
Santee, C. A., Nagalingam, N. A., Faruqi, A. A., DeMuri, G. P., Gern, J. E., Wald, E. R., & Lynch, S. V. (2016). Nasopharyngeal microbiota composition of children is related to the frequency of upper respiratory infection and acute sinusitis. Microbiome, 4(1), 34.
Silverman, M., Povitz, M., Sontrop, J. M., Li, L., Richard, L., Cejic, S., & Shariff, S. Z. (2017). Antibiotic prescribing for nonbacterial acute upper respiratory infections in elderly persons. Annals of Internal Medicine, 166(11), 765–774.
Create your account
Always verify citation format against your institution’s current style guide requirements.